Revised USP Chapter <383> Cured Silicone Elastomers
Recommendation

19/20 May 2026
All relevant GMP/GACP aspects for Medical Cannabis
In Pharmacopeial Forum (PF) 50(6), the USP General Chapters—Packaging and Distribution Expert Committee (GCPD) published a revised version of USP's new chapter <383> Cured Silicone Elastomers for Pharmaceutical Packaging and Manufacturing Components. The draft chapter is open for comments until 31 January 2025. The new USP chapter <383> will become official on 1 December 2027. However, early adoption of the requirements in this chapter is permitted by USP.
Proposed Changes to USP Chapter <383>
The GCPD is proposing the following revisions to address comments received with the publication of the new USP chapter <383> in March 2024. The following changes are proposed:
- Revise the Scope to clarify the applicability of the chapter to cured silicone elastomers used for manufacturing components. The scope of the chapter includes elastomeric closures for pharmaceutical packaging and components used in the manufacturing of drug products and active pharmaceutical ingredients, such as diaphragms, gaskets, O-rings, and tubing.
- Move the Iodine solution preparation procedure from the Physicochemical Tests, Residual peroxides section to the Physicochemical Tests, Reducing substances section.
- Delete Procedure 1 and Acceptance criteria 1 (titration with sodium thiosulfate) from the Physicochemical Tests, Residual peroxides section.
More information is available after registration to the USP Pharmacopeial Forum.
Related GMP News
22.04.2026Roadmap for the Introduction of the Electronic Package Leaflet
15.04.2026Revision of Ph. Eur. Chapter on Extractables in Plastic Materials
08.04.2026What are the GMP Requirements for Pharmaceutical Packaging Materials?
26.03.2026ICH Q3E: EMA publishes Comments Received
11.03.2026Revised USP Chapter <382> Elastomeric Component Functional Suitability
04.03.2026Revised USP Chapter <661> Plastic Packaging Systems and Their Materials of Construction


